Oliver Catlin, President of BSCG, shares his perspective on the FDA's consideration of peptides for the 503A Bulks List, what it means from a safety and efficacy standpoint, and why the outcome matters to the broader supplement industry
Wang YQ, Jiang YJ, Zou MS, Liu J, Zhao HQ, Wang YH (2022) Antidepressant actions of melatonin and melatonin receptor agonist: focus on pathophysiology and treatment
Patients with glutathione synthetase deficiency typically present in the neonatal period with hemolytic anemia, metabolic acidosis and neurological impairment
Emerging evidence that highly localized on-demand synthesis of estradiol, making this steroid more akin to a neurotransmitter (19), further comprises our ability to mimic or fully antagonize the actions of this ubiquitous and potent signaling molecule